Introduction: If sympathetic hyperactivity seems to be associated to several components of the metabolic syndrome, its involvement in the development of metabolic syndrome has not been clearly defined.
Results: No significant difference on triglycerides or cholesterol rates could be detected after the 15 weeks period. Heterozygous mice displayed clear glucose intolerance already before starting the fructose diet (area under the curve (%)=25434 vs 20822, p=0.013 for +/-and +/+ mice respectively). These animals were also much more sensitive to high fructose, since a 50% increase in the area under the curve of the IPGTT was obtained at the end of the high fructose diet, compared to the 11% increase in +/+ mice.
Conclusion:
Our data suggest that constitutive chronic sympathetic hyperactivity can induce the early development of carbohydrate metabolism disorders. Moreover, it seems to represent a major factor of susceptibility to dietinduced metabolic dysfunction.
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Introduction: Determination of adipose tissue proportion, as well as its spatial distribution, is a major part of metabolic syndrome assessment. Various methods, commonly used in mouse models, are either indirect measurement, invasive (destructive) or imaging techniques. Indirect measurement techniques, such as deuterium dilution (considered as gold standard) or bioimpedance are based on the measurement of body composition. They give access to the measure of total body fat, without distinction between visceral and subcutaneous fat volumes. Sacrifice and ex-vivo tissue weight allow both total fat measurement and partition between subcutaneous and visceral fat pad. It is a direct method that does not allow for longitudinal studies. Non-invasive micro-imaging modalities (magnetic resonance imaging and μCT) add, over others, the advantage of spatial localization of fat, in vivo.
Aim: Of our study was to compare results of measurements of total body fat done by μCT and bioimpedance in mice.
Methods: μCT was done using a dedicated in vivo imaging instrument (eXplore Vision 120, GE, USA) on 30 anesthetized mice. Each acquisition lasted approximately 12 min. Just after μCT, measurement of body composition was performed by bioimpedance (ImpediVET, ImpediMed, USA).
Results:
The average value of total body fat by μCT is 5% higher than that obtained by bioimpedance. The standard deviation calculated from μCT measurements is lower than that obtained with bioimpedance (4.8% vs 6.8% respectively). The linear correlation of μCT and bioimpedance measure of total adipose tissue is moderate (r² = 0.55).
Conclusion:
It is the first time, to our knowledge, that a comparison of total fat volume measurement between μCT and bioimpedance is performed in mice. Surprisingly, the correlation appears not to be so trivial between the 2 methods. Before a deeper exploration, comparison of results obtained with these 2 methods should be made with caution.
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Prevalence of the metabolic syndrome in psoriasis patients: morroccan experience
Background: Psoriasis is a chronic inflammatory disease associated with multiple comorbidities that are components of the metabolic syndrome (MS). Several studies have objectified a high prevalence of MS in psoriasis patients.
Objective: To determine the prevalence of MS and its components in psoriasis patients compared with controls, also the factors determinants the occurrence of MS in our patients.
Patients and Methods:
This was a prospective study including 100 psoriasis patients versus 100 controls seen in consultation or in hospitals. Conducted for a period of 12 months.
Results:
The prevalence of MS was higher in patients with psoriasis compared with controls (OR=2.89, p=0,0002). With a significant increase in obesity (OR=3.25, p=0.001), hypertriglyceridemia (OR=3.9, p=0.013) and glucose intolerance (OR = 2.13, p = 0.046). Risk factors determining the appearance of SM in psoriatic were age, family history of psoriasis, seniority of psoriasis, but we did not find a correlation with sex, severity of psoriasis and the clinical form.
Conclusion:
The management of psoriasis will integrate research risk factors for a possible metabolic syndrome and its treatment through a multidisciplinary approach.
